Tag Archives: Staci R Stevens

Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing

Posted on March 27, 2019 by wames

Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing, by Jerome Bouquet, Tony Li, Jennifer L Gardy, Xiaoying Kang, Staci Stevens, Jared Stevens, Mark VanNess, Christopher Snell, James Potts, Ruth R Miller, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing

Chronotropic Intolerance: an overlooked determinant of symptoms & activity limitation in ME/CFS?

Posted on March 25, 2019 by wames

Chronotropic intolerance: an overlooked determinant of symptoms and activity limitation in myalgic encephalomyelitis/chronic fatigue syndrome?, by Todd E. Davenport,  Mary Lehnen,  Staci R Stevens,  J. Mark VanNess,  Jared Stevens and  Christopher R Snell in Front. Pediatr. 22 March 2019 Review … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Chronotropic Intolerance: an overlooked determinant of symptoms & activity limitation in ME/CFS?

Cardiopulmonary exercise test methodology for assessing exertion intolerance in ME/CFS

Posted on September 7, 2018 by wames

Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in ME/CFS by Staci Stevens, Chris Snell, Jared Stevens, Betsy Keller and J Mark VanNess in Frontiers in Pediatrics, 4 September 2018 Background: Concise methodological directions for administration of serial cardiopulmonary exercise testing (CPET) … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Cardiopulmonary exercise test methodology for assessing exertion intolerance in ME/CFS

Checking our blind spots: current status of research evidence summaries in ME/CFS

Posted on July 23, 2018 by wames

Checking our blind spots: current status of research evidence summaries in ME/CFS, by Todd E Davenport, Staci R Stevens, J Mark VanNess, Jared Stevens, Christopher R Snell in British Journal of Sports Medicine, July 2018 Editorial: The evidence-based practice (EBP) … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Checking our blind spots: current status of research evidence summaries in ME/CFS

Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)

Posted on September 29, 2015 by wames

Research abstract: Background: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating disease of unknown pathogenesis consisting of  a variety of flu-like symptoms including severe fatigue. Initial analysis of the use of rintatolimod (Poly I: Poly C12U), a selective TLR3 agonist, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)